EVERSANA’s Post

How patient-centric is the pharma industry? 🤔 This question lingered at last week's Patient Centricity and Engagement conference in London. The alignment between patient advocates and industry voices on patient involvement was powerful, but the conversations revealed we’ve got work to do to get to where we want to go. Key insights I’m taking back to Stitch: 📈 ROI drives action: Patient engagement must show clear value. 💯 All-in commitment: It’s everyone’s job, not just one department’s. 🏥 Direct support matters: The industry drives value with toolkits and support for sites and patients. Thanks to the organisers for a great event. Looking forward to next year 

Don't miss FrontierView's Strategic Webinar on Balancing Channels to Drive Promotional Activities in Healthcare. Join us online using the links below on either dates: (Americas Eastern Time): February 20, 9am EST: https://lnkd.in/dMMqkCNM (Asia Pacific Time) February 22, 9am SGT: https://lnkd.in/dzKm6Pqf Following the publication of our analysis on the FV Platform, my colleagues Alec Lee and Sunny Y. Xu will be moderating a 60-min webinar on two different timezones to guide healthcare leaders through a complex journey by discussing challenges and offering insights that will empower their healthcare business. The global pandemic has changed the way healthcare companies engage with stakeholders across the healthcare ecosystem. To stay relevant and competitive in the post-pandemic world, a strategic and balanced approach that combines both analog and digital engagement methods is imperative. We will share real world case studies to highlight best practices in hybrid engagement implementation and introduce a framework to facilitate optimization of key executional workflows. #hybrid #healthcare #pharma #medicaldevices #medtech #medtechinnovation #diagnostics #realworlddata

Ready to close more deals and make a real impact? In today’s complex healthcare landscape, success hinges on building relationships with the people who will truly champion your solution. This recent DH blog  breaks down the critical importance of KOLs and decision-makers and how to leverage their influence to skyrocket sales and improve patient outcomes. Check it out! https://lnkd.in/esPTWQr4

Strengthening #healthequity is a key driver of better universal health outcomes, and ensuring people have equal access to relevant health information and care is a top priority of many executives in the #healthcare and #lifesciences industries. To support this critical initiative, #marketers must work to battle misinformation, adopt #digital best practices, and ensure the brands they represent have access to the data to uncover #insights to better engage underserved or vulnerable populations. Join us on April 23 to discover how healthcare marketers can play a critical role by using data to accelerate progress in building more equity. There will be an opportunity to ask questions during the live event. #pharma #data #healthdata

June is our Patient Centricity Month, where we shine a light on how and why we put patients at the heart of all that we do. Astellas’ Patient Centricity Function was set up in 2019, and in the five years since then, we have:  ✓ Created 5 Patient Centricity (PAT-C) Functional Unit teams.  ✓ Defined the essential operational and cultural components for achieving our patient centricity vision.  ✓ Included Patient Centricity in our 2021 Corporate Strategic Plan.  ✓ Committed to our annual Patient Centricity Month.  ✓ Launched the Patient Centricity Solve-a-Thon, where employees can turn their ideas into real patient solutions.  ✓ Launched the PATIENTS ARE WHY™ brand to unite our patient centric activities.  ✓ Won the Reuters Patient Champion Award, which recognized our actions to bring patient insights into our culture.  ✓ Established Patient Centricity University, a learning hub to make our work more patient centric.  ✓ Delivered our first Patient Partnerships Annual Report.   ✓ Embedded a patient centric culture across all business functions. Looking ahead to the next five years, we hope every company and stakeholder will be focused on what matters most to patients. We are working to help other pharma companies adopt our approach. We will also use our experience to help drive change across entire healthcare systems.  Find out more about Patient Centricity at Astellas: https://lnkd.in/g8Sj8AGb #PatientCentricityMonth2024 #PATIENTSAREWHY

Are you struggling to communicate the true value of your treatments? At Relevate Health, we're not just another partner - we're your market access accelerator. What sets us apart? Precision Messaging: We craft clinical and economic value stories that resonate. Strategic Execution: Our commercial plans turn potential into performance. Value Maximization: We drive differentiation, optimize access, and enhance patient support. All powered by data-driven insights and tailored to your unique needs. Ready to exceed your commercial objectives? Let's talk. https://bit.ly/3YWP0sb #LifeSciences #MarketAccess #HealthcareInnovation

The IQVIA Payer Analytics Suite offers robust analytic capabilities, transforming prescription claim data into actionable insights. Developed specifically for Payers to gain insights across the IQVIA ecosystem of Rx Claims, we provide interactive dashboards to identify and understand opportunities. The Payer Analytic Suite empowers Payers to:   Enhance Health Outcomes and Competitive Edge: ·      Drive insights aimed at improving health outcomes and fostering competitive differentiation.   Understand Member Spend and Utilization: ·      Determine member spend and utilization, both within and outside of Payer Benefits, for a comprehensive understanding of member behavior.   Spot Provider Prescribing Trends and Anomalies: ·      Identify trends and anomalies in provider prescribing patterns, offering valuable insights for decision-making.   Conduct Targeted Analytics on Specialty Drugs: ·      Perform targeted analytics specifically focused on specialty drugs, with the added ability to establish baselines against the broader market landscape.     Our hosted analytics platform ensures rapid access to these insights, eliminating the need for complex integrations or extensive technology setup. It's a streamlined solution designed to empower Payers with the intelligence needed to navigate the complexities of the healthcare landscape effectively. https://lnkd.in/gSw5KMFD

Elevating Market Access: Strategies for Thriving in a Value-Based Healthcare Environment”, we explore the key strategies that 22 top pharma companies are leveraging to stay competitive. 🏆

Is your pharma marketing strategy stuck in the past? It's time to evolve! In the first part of a two-part series, Uttama Rath, PhD, SVP Medical and Megan Jones , COO discuss: - How digital engagement is reshaping payer communications - Critical strategies for thriving in the new market access landscape - Why embracing digital is no longer optional, but essential Ready to transform your market access approach? 🔗 https://bit.ly/3Tzgtfh #MarketAccess #DigitalStrategy #PharmaMarketing

🌟 Shaping the Future of Healthcare 🌟 Calling all Market Access Leaders in the biopharma industry! 🚀 Let's talk about the transformative power of integrated evidence generation on your workflows, be it through EHR, claims data, or beyond. 🔹 Integrated evidence generation empowers you to make informed decisions based on comprehensive real-world data. 🔹 By leveraging data from sources like EHR and claims data, you gain valuable insights into product performance and patient outcomes. 🔹 A 360-degree view of your products' performance allows you to identify opportunities, demonstrate value, and drive better patient outcomes. 🔹 Embracing integrated evidence generation is about breaking down silos and shaping the future of medicine through collaboration and data-driven insights. Fellow Market Access Leaders, let's continue to push boundaries, challenge the status quo, and lead the way towards a more accessible, equitable healthcare system. 👏 Together, we have the power to transform lives and make a difference. Keep innovating, keep advocating, and keep striving for excellence. The impact we create is immeasurable! Cheers to all Market Access Leaders driving change every day. Your dedication to improving patient access to innovative therapies is commendable. Let's embrace the power of integrated evidence generation and pave the way for a brighter, healthier future for all. #MarketAccessLeaders #Biopharma #HealthcareInnovation #IntegratedEvidenceGeneration